Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

French athlete handed six-month ban for doping
eventing
Livio and the French eventing team lost their slot in the Rio 2016 Olympic Games after the horse tested positive for a banned substance. (stock image)
Sanctions follow failed drugs test

French eventer Maxime Livio has been handed a fine and banned for six months after horse Qalao des Mers tested positive for a controlled medication substance.

A sample taken from the horse on 29 August last year tested positive for hydroxyethylpromazine sulfoxide, which is a metabolite of acepromazine.

After the findings were revealed last month, Livio and the French eventing team were disqualified from the FEI World Equestrian Games 2014. As a result, France lost its slot in the Rio 2016 Olympic Games.

As well as a six-month ban on Livio, which came into effect on 7 May, the FEI Tribunal ordered the athlete to pay CHF 2,500 in addition to covering the costs of the B sample analysis and contributing to the judicial procedure costs.

Acepromazine is a controlled medication substance on the FEI prohibited substances list. The list comprises substances that are regularly used to treat horses but are prohibited in competitions to maintain a level playing field.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'